Director · Indivior Pharmaceuticals, Inc. · INDIVIOR PLC
Side
BUY
Value
$27K
Shares
775
Price
$35.39
Executed
Jan 5, 2026
Disclosed
Jan 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 5 executedJan 7, 2026 disclosed
INDV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Humphreys Keith filed this Form 4 reporting a open-market purchase of INDV on Jan 5, 2026. It became public on Jan 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Humphreys Keithcik:0002014900
Issuer
Indivior Pharmaceuticals, Inc.cik:0001625297
Revision history · 0
No field has changed since this record was first ingested.
